1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

02 May 2022
Admin
News Article

Novavax Announces Us Fda Vrbpa Committee To Review Its Nvx-Cov2373 Covid-19 Vaccine

Novavax, Inc., A Biotechnology Company, Announced That The Us Food And Drug Administration'S (Fda) Vaccines And Related Biological Products Advisory Committee (Vrbpac) Will Review Nvx-Cov2373 Covid-19 Vaccine (Recombinant, Adjuvanted) For Active Immunization Against Sars-Cov-2 At A Meeting Scheduled For June 7, 2022. Vrbpac Reviews And Evaluates Data Regarding The Safety And Efficacy Of Vaccines And Related Biological Products That Are Intended For Use In The Prevention, Treatment, Or Diagnosis Of Human Diseases."We Continue To Hear From Physicians, Healthcare Organizations, And Consumers Who Are Anxiously Awaiting Another Vaccine Option. We Believe Our Vaccine, Built On A Well-Understood Protein-Based Vaccine Platform, Can Play A Part In Fulfilling This Need," Said Stanley C. Erck, President And Chief Executive Officer, Novavax. "We Look Forward To A Productive Vrbpac Meeting And Will Continue To Work With The Fda Throughout The Review Process."Novavax Submitted A Request To The Fda For Emergency Use Authorization (Eua) For Nvx-Cov2373 In January 2022 Based On The Totality Of Pre-Clinical, Clinical, And Manufacturing-Related Data Provided To The Agency.Nvx-Cov2373 Is A Protein-Based Vaccine Engineered From The Genetic Sequence Of The First Strain Of Sars-Cov-2, The Virus That Causes Covid-19 Disease. Nvx-Cov2373 Was Created Using Novavax' Recombinant Nanoparticle Technology To Generate Antigen Derived From The Coronavirus Spike (S) Protein And Is Formulated With Novavax' Patented Saponin-Based Matrix-M Adjuvant To Enhance The Immune Response And Stimulate High Levels Of Neutralizing Antibodies. Nvx-Cov2373 Contains Purified Protein Antigen And Can Neither Replicate, Nor Can It Cause Covid-19.Novavax' Covid-19 Vaccine Is Packaged As A Ready-To-Use Liquid Formulation In A Vial Containing Ten Doses. The Vaccination Regimen Calls For Two 0.5 Ml Doses (5 Mcg Antigen And 50 Mcg Matrix-M Adjuvant) Given Intramuscularly 21 Days Apart. The Vaccine Is Stored At 2

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!